Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
9Customers
1Debt Items
13Related Chains
Source-Backed Evidence Depth
Maravai LifeSciences Holdings, Inc. (MRVI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
2Distinct source URLs
3High confidence
0.715Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Maravai LifeSciences Holdings, Inc. Suppliers
No suppliers on recordMaravai LifeSciences Holdings, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: able were $ million during the year…
able were $ million during the year ended December 31, 2024 . Write-offs of accounts receivable were significant during the years ended December 31, 2023 and 2022. Recoveri es were significant during…
GTCR-LLC
GTCR-LLC
62%
chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
MARAVAI-LIFE-SCIENCES-HOLDINGS
MARAVAI-LIFE-SCIENCES-HOLDINGS
62%
chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
MARAVAI-LIFE-SCIENCES-HOLDINGS-LLC
MARAVAI-LIFE-SCIENCES-HOLDINGS-LLC
62%
chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
MOLECULAR-ASSEMBLIES-INC
MOLECULAR-ASSEMBLIES-INC
62%
alue on a recurring basis. Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and account…
MYCHEM-LLC
MYCHEM-LLC
62%
our industry or across different industries. Components of Results of Operations Revenue Our revenue consists primarily of product revenue and, to a much lesser extent, service revenue. We generated …
TOPCO-LLC-OPERATING-AGREEMENT-TOPCO-LLC
TOPCO-LLC-OPERATING-AGREEMENT-TOPCO-LLC
62%
uring the three months ended March 31, 2026 and 2025, the Company did not recognize a material amount of revenue that was included in the contract liabilities balances as of December 31, 2025 and 202…
Maravai LifeSciences Holdings, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MRVI-DEBT
Debt stack $147.1M
90%
Market cache reports total debt of $147.1M.
Maravai LifeSciences Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Maravai LifeSciences Holdings, Inc..
Maravai LifeSciences Holdings, Inc. Ownership
Holder
Name
Confidence
Evidence
MRVI-OWNER-GTCR-LLC
GTCR LLC
90%
13F overlay lists GTCR LLC as top holder; 161 tracked holders.
Maravai LifeSciences Holdings, Inc. Extended Supply Chain Network
